CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma.

Saved in:
Bibliographic Details
Title: CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma.
Authors: Xiong, Shuzhen1 (AUTHOR), Yue, Ningning1 (AUTHOR), Zhang, Shuni1 (AUTHOR), Xu, Yu1 (AUTHOR), Cao, Jiajia1 (AUTHOR), Liu, Xinyang1 (AUTHOR), Wu, Chongyang1 (AUTHOR) wuchy0909@163.com
Source: Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1458-1478. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2661769